Heterogeneous pathological outcomes after experimental pH1N1 influenza infection in ferrets correlate with viral replication and host immune responses in the lung

Veterinary Research

Volumn 45, Issue 1, 2014, Pages

  Vidaña, Beatriz ^a,b   Martínez, Jorge ^a,b   Martínez Orellana, Pamela ^b   García Migura, Lourdes ^b   Montoya, María ^b,c   Martorell, Jaime ^a   Majó, Natàlia ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b CENTRE DE RECERCA EN SANITAT ANIMAL CRESA   (Spain)

^c IRTA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MESSENGER RNA; TOLL LIKE RECEPTOR; TRANSCRIPTOME;

ANIMAL; APOPTOSIS; FEMALE; FERRET; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); LUNG; MALE; METABOLISM; ORTHOMYXOVIRUS INFECTION; PATHOLOGY; PHYSIOLOGY; RANDOMIZATION; VETERINARY; VIROLOGY; VIRUS REPLICATION;

ANIMALS; APOPTOSIS; CYTOKINES; FEMALE; FERRETS; GENE EXPRESSION REGULATION, VIRAL; INFLUENZA A VIRUS, H1N1 SUBTYPE; LUNG; MALE; ORTHOMYXOVIRIDAE INFECTIONS; RANDOM ALLOCATION; RNA, MESSENGER; TOLL-LIKE RECEPTORS; TRANSCRIPTOME; VIRUS REPLICATION;

EID: 84907045795     PISSN: 09284249     EISSN: 12979716     Source Type: Journal    
DOI: 10.1186/s13567-014-0085-8     Document Type: Article

References (65)

1. Statement to the press by WHO Director-General Dr. Margaret Chan. http://www.who.int/mediacentre/news/statements/2009/h1n1-pandemic-phase6-20090611/en/index.html [http://www.who.int/mediacentre/news/statements/2009/h1n1-pandemic-phase6-20090611/en/index.html] (Accessed June 11, 2009)
2. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. S Jain, L Kamimoto, AM Bramley, AM Schmitz, SR Benoit, J Louie, DE Sugerman, JK Druckenmiller, KA Ritger, R Chugh, S Jasuja, M Deutscher, S Chen, JD Walker, JS Duchin, S Lett, S Soliva, EV Wells, D Swerdlow, TM Uyeki, AE Fiore, SJ Olsen, AM Fry, CB Bridges, L Finelli, N Engl J Med 2009 361 1935 1944 10.1056/NEJMoa0906695 19815859
3. Influenza 2010-2011: lessons from the 2009 pandemic. MG Ison, N Lee, Cleve Clin J Med 2010 77 812 820 10.3949/ccjm.77a.10135 21048054
4. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. E Bautista, T Chotpitayasunondh, Z Gao, SA Harper, M Shaw, TM Uyeki, SR Zaki, FG Hayden, DS Hui, JD Kettner, A Kumar, M Lim, N Shindo, C Penn, KG Nicholson, N Engl J Med 2010 362 1708 1719 10.1056/NEJMra1000449 20445182
5. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Y Itoh, K Shinya, M Kiso, T Watanabe, Y Sakoda, M Hatta, Y Muramoto, D Tamura, Y Sakai-Tagawa, T Noda, S Sakabe, M Imai, Y Hatta, S Watanabe, C Li, S Yamada, K Fujii, S Murakami, H Imai, S Kakugawa, M Ito, R Takano, K Iwatsuki-Horimoto, M Shimojima, T Horimoto, H Goto, K Takahashi, A Makino, H Ishigaki, M Nakayama, Nature 2009 460 1021 1025 19672242
6. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JK Louie, M Acosta, K Winter, C Jean, S Gavali, R Schechter, D Vugia, K Harriman, B Matyas, CA Glaser, MC Samuel, J Rosenberg, J Talarico, D Hatch, JAMA 2009 302 1896 1902 10.1001/jama.2009.1583 19887665
7. Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. JR Gill, ZM Sheng, SF Ely, DG Guinee, MB Beasley, J Suh, C Deshpande, DJ Mollura, DM Morens, M Bray, WD Travis, JK Taubenberger, Arch Pathol Lab Med 2010 134 235 243 20121613
8. Emerging influenza. E de Wit, RA Fouchier, J Clin Virol 2008 41 1 6 10.1016/j.jcv.2007.10.017 18340670
9. Genomic polymorphism of the pandemic A (H1N1) influenza viruses correlates with viral replication, virulence, and pathogenicity in vitro and in vivo. L Xu, L Bao, J Zhou, D Wang, W Deng, Q Lv, Y Ma, F Li, H Sun, L Zhan, H Zhu, C Ma, Y Shu, C Qin, PLoS One 2011 6 20698 10.1371/journal.pone.0020698 21698272
10. Virulence differences of closely related pandemic 2009 H1N1 isolates correlate with increased inflammatory responses in ferrets. I Meunier, C Embury-Hyatt, S Stebner, M Gray, N Bastien, Y Li, F Plummer, GP Kobinger, V von Messling, Virology 2012 422 125 131 10.1016/j.virol.2011.10.018 22074911
11. Characterization in vitro and in vivo of a pandemic H1N1 influenza virus from a fatal case. A Rodriguez, A Falcon, MT Cuevas, F Pozo, S Guerra, B Garcia-Barreno, P Martinez-Orellana, P Perez-Brena, M Montoya, JA Melero, M Pizarro, J Ortin, I Casas, A Nieto, PLoS One 2013 8 53515 10.1371/journal.pone.0053515 23326447
12. Molecular characterization of severe and mild cases of influenza A (H1N1) 2009 strain from Argentina. E Baumeister, G Palacios, D Cisterna, A Solovyov, J Hui, N Savji, AV Bussetti, A Campos, A Pontoriero, OJ Jabado, C Street, DL Hirschberg, R Rabadan, V Alonio, V Molina, S Hutchison, M Egholm, WI Lipkin, Medicina (B Aires) 2010 70 518 523
13. Cytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adults. N Lee, CK Wong, PK Chan, MC Chan, RY Wong, SW Lun, KL Ngai, GC Lui, BC Wong, SK Lee, KW Choi, DS Hui, PLoS One 2011 6 26050 10.1371/journal.pone.0026050 22022504
14. Immunogenetic factors associated with severe respiratory illness caused by zoonotic H1N1 and H5N1 influenza viruses. J Juno, KR Fowke, Y Keynan, Clin Dev Immunol 2012 2012 797180 10.1155/2012/797180 22110538
15. Chemokine receptor 5Δ32 allele in patients with severe pandemic (H1N1) 2009. Y Keynan, J Juno, A Meyers, TB Ball, A Kumar, E Rubinstein, KR Fowke, Emerg Infect Dis 2010 16 1621 1622 10.3201/eid1610.100108 20875295
16. The role of polymorphisms in host immune genes in determining the severity of respiratory illness caused by pandemic H1N1 influenza. Y Keynan, S Malik, KR Fowke, Public Health Genomics 2013 16 9 16 10.1159/000345937 23548712
17. Host adaptive immunity deficiency in severe pandemic influenza. JF Bermejo-Martin, I Martin-Loeches, J Rello, A Anton, R Almansa, L Xu, G Lopez-Campos, T Pumarola, L Ran, P Ramirez, D Banner, DC Ng, L Socias, A Loza, D Andaluz, E Maravi, MJ Gómez-Sánchez, M Gordón, MC Gallegos, V Fernandez, S Aldunate, C León, P Merino, J Blanco, F Martin-Sanchez, L Rico, D Varillas, V Iglesias, MÁ Marcos, F Gandía, et al. Crit Care 2010 14 167 10.1186/cc9259 20840779
18. Pathogenicity of different PR8 influenza A virus variants in mice is determined by both viral and host factors. P Blazejewska, L Koscinski, N Viegas, D Anhlan, S Ludwig, K Schughart, Virology 2011 412 36 45 10.1016/j.virol.2010.12.047 21256531
19. The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype. AC Boon, G de Mutsert, YM Graus, RA Fouchier, K Sintnicolaas, AD Osterhaus, GF Rimmelzwaan, J Virol 2002 76 582 590 10.1128/JVI.76.2.582-590.2002 11752149
20. Toll-like receptor 3 gene polymorphisms and severity of pandemic A/H1N1/2009 influenza in otherwise healthy children. S Esposito, CG Molteni, S Giliani, C Mazza, A Scala, L Tagliaferri, C Pelucchi, E Fossali, A Plebani, N Principi, Virol J 2012 9 270 10.1186/1743-422X-9-270 23151015
21. Role of tumor necrosis factor gene single nucleotide polymorphisms in the natural course of 2009 influenza A H1N1 virus infection. A Antonopoulou, F Baziaka, T Tsaganos, M Raftogiannis, P Koutoukas, A Spyridaki, M Mouktaroudi, A Kotsaki, A Savva, M Georgitsi, EJ Giamarellos-Bourboulis, Int J Infect Dis 2012 16 204 208 10.1016/j.ijid.2011.11.012 22269998
22. IFITM3 restricts the morbidity and mortality associated with influenza. AR Everitt, S Clare, T Pertel, SP John, RS Wash, SE Smith, CR Chin, EM Feeley, JS Sims, DJ Adams, HM Wise, L Kane, D Goulding, P Digard, V Anttila, JK Baillie, TS Walsh, DA Hume, A Palotie, Y Xue, V Colonna, C Tyler-Smith, J Dunning, SB Gordon, RL Smyth, PJ Openshaw, G Dougan, AL Brass, P Kellam, Nature 2012 484 519 523 10.1038/nature10921 22446628
23. Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G(2) subclass deficiency. CL Gordon, PD Johnson, M Permezel, NE Holmes, G Gutteridge, CF McDonald, DP Eisen, AJ Stewardson, J Edington, PG Charles, N Crinis, MJ Black, J Torresi, ML Grayson, Clin Infect Dis 2010 50 672 678 20121412
24. Genetic variants associated with severe pneumonia in A/H1N1 influenza infection. J Zuniga, I Buendia-Roldan, Y Zhao, L Jimenez, D Torres, J Romo, G Ramirez, A Cruz, G Vargas-Alarcon, CC Sheu, F Chen, L Su, AM Tager, A Pardo, M Selman, DC Christiani, Eur Respir J 2012 39 604 610 10.1183/09031936.00020611 21737555
25. A simple method of estimating fifty per cent endpoints. LJ Reed, H Muench, Am J Hyg 1938 27 493 497
26. Technical considerations for developing enzyme immunohistochemical staining procedures on formalin-fixed paraffin-embedded tissues for diagnostic pathology. DM Haines, BJ Chelack, J Vet Diagn Invest 1991 3 101 112 10.1177/104063879100300128 2039784
27. Experimental infection with H1N1 European swine influenza virus protects pigs from an infection with the 2009 pandemic H1N1 human influenza virus. N Busquets, J Segalés, L Córdoba, T Mussá E Crisci, GE Martín-Valls, M Simon-Grifé M Pérez-Simó M Pérez-Maíllo, JI Núñez, FX Abad, L Fraile, S Pina, N Majó A Bensaid, M Domingo, M Montoya, Vet Res 2010 41 74 10.1051/vetres/2010046 20663475
28. A method for the rapid construction of cRNA standard curves in quantitative real-time reverse transcription polymerase chain reaction. S Fronhoffs, G Totzke, S Stier, N Wernert, M Rothe, T Bruning, B Koch, A Sachinidis, H Vetter, Y Ko, Mol Cell Probes 2002 16 99 110 10.1006/mcpr.2002.0405 12030760
29. Immune system cells in healthy ferrets: an immunohistochemical study. B Vidaña, N Majó M Pérez, M Montoya, J Martorell, J Martínez, Vet Pathol 2013 55 775 786
30. Differential pathological and immune responses in newly weaned ferrets are associated with a mild clinical outcome of pandemic 2009 H1N1 infection. SS Huang, D Banner, N Degousee, AJ Leon, L Xu, SG Paquette, T Kanagasabai, Y Fang, S Rubino, B Rubin, DJ Kelvin, AA Kelvin, J Virol 2012 86 13187 13201 10.1128/JVI.01456-12 23055557
31. Molecular characterization of in vivo adjuvant activity in ferrets vaccinated against influenza virus. Y Fang, T Rowe, AJ Leon, D Banner, A Danesh, L Xu, L Ran, SE Bosinger, Y Guan, H Chen, CC Cameron, MJ Cameron, DJ Kelvin, J Virol 2010 84 8369 8388 10.1128/JVI.02305-09 20534862
32. NCBI nucleotide database. http://www.ncbi.nlm.nih.gov/nuccore [http://www.ncbi.nlm.nih.gov/nuccore]
33. Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice. JA Belser, DA Wadford, C Pappas, KM Gustin, TR Maines, MB Pearce, H Zeng, DE Swayne, M Pantin-Jackwood, JM Katz, TM Tumpey, J Virol 2010 84 4194 4203 10.1128/JVI.02742-09 20181710
34. Local innate immune responses and influenza virus transmission and virulence in ferrets. TR Maines, JA Belser, KM Gustin, N van Hoeven, H Zeng, N Svitek, V von Messling, JM Katz, TM Tumpey, J Infect Dis 2012 205 474 485 10.1093/infdis/jir768 22158704
35. Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. VJ Munster, E de Wit, JM van den Brand, S Herfst, EJ Schrauwen, TM Bestebroer, D van de Vijver, CA Boucher, M Koopmans, GF Rimmelzwaan, T Kuiken, AD Osterhaus, RA Fouchier, Science 2009 325 481 483 19574348
36. The ferret as a model organism to study influenza A virus infection. JA Belser, JM Katz, TM Tumpey, Dis Model Mech 2011 4 575 579 10.1242/dmm.007823 21810904
37. 2009 pandemic H1N1 influenza A virus strains display differential pathogenicity in C57BL/6 J but not BALB/c mice. A Otte, G Gabriel, Virulence 2011 2 563 566 10.4161/viru.2.6.18148 22030859
38. The role of host genetics in susceptibility to influenza: a systematic review. P Horby, NY Nguyen, SJ Dunstan, JK Baillie, PLoS One 2012 7 33180 10.1371/journal.pone.0033180 22438897
39. Comparative pathology of select agent influenza a virus infections. T Kuiken, J van den Brand, D van Riel, M Pantin-Jackwood, DE Swayne, Vet Pathol 2010 47 893 914 10.1177/0300985810378651 20682805
40. Into the eye of the cytokine storm. JR Tisoncik, MJ Korth, CP Simmons, J Farrar, TR Martin, MG Katze, Microbiol Mol Biol Rev 2012 76 16 32 10.1128/MMBR.05015-11 22390970
41. A question of self-preservation: immunopathology in influenza virus infection. NL La Gruta, K Kedzierska, J Stambas, PC Doherty, Immunol Cell Biol 2007 85 85 92 10.1038/sj.icb.7100026 17213831
42. Matrix metalloprotease 9 mediates neutrophil migration into the airways in response to influenza virus-induced toll-like receptor signaling. LM Bradley, MF Douglass, D Chatterjee, S Akira, BJ Baaten, PLoS Pathog 2012 8 1002641 10.1371/journal.ppat.1002641 22496659
43. Comparison of temporal and spatial dynamics of seasonal H3N2, pandemic H1N1 and highly pathogenic avian influenza H5N1 virus infections in ferrets. JM van den Brand, KJ Stittelaar, G van Amerongen, L Reperant, L de Waal, AD Osterhaus, T Kuiken, PLoS One 2012 7 42343 10.1371/journal.pone.0042343 22905124
44. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. LA Perrone, JK Plowden, A Garcia-Sastre, JM Katz, TM Tumpey, PLoS Pathog 2008 4 1000115 10.1371/journal.ppat.1000115 18670648
45. Critical role of IL-1 receptor-associated kinase-M in regulating chemokine-dependent deleterious inflammation in murine influenza pneumonia. M Seki, S Kohno, MW Newstead, X Zeng, U Bhan, NW Lukacs, SL Kunkel, TJ Standiford, J Immunol 2010 184 1410 1418 10.4049/jimmunol.0901709 20042589
46. Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. AC Monsalvo, JP Batalle, MF Lopez, JC Krause, J Klemenc, JZ Hernandez, B Maskin, J Bugna, C Rubinstein, L Aguilar, L Dalurzo, R Libster, V Savy, E Baumeister, L Aguilar, G Cabral, J Font, L Solari, KP Weller, J Johnson, M Echavarria, KM Edwards, JD Chappell, JE Crowe Jr, JV Williams, GA Melendi, FP Polack, Nat Med 2011 17 195 199 10.1038/nm.2262 21131958
47. Lung pathology in fatal novel human influenza A (H1N1) infection. T Mauad, LA Hajjar, GD Callegari, LF da Silva, D Schout, FR Galas, VA Alves, DM Malheiros, JO Auler Jr, AF Ferreira, MR Borsato, SM Bezerra, PS Gutierrez, ET Caldini, CA Pasqualucci, M Dolhnikoff, PH Saldiva, Am J Respir Crit Care Med 2010 181 72 79 10.1164/rccm.200909-1420OC 19875682
48. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. JR Teijaro, KB Walsh, S Cahalan, DM Fremgen, E Roberts, F Scott, E Martinborough, R Peach, MB Oldstone, H Rosen, Cell 2011 146 980 991 10.1016/j.cell.2011.08.015 21925319
49. Hyperactive immune cells (T cells) may be responsible for acute lung injury in influenza virus infections: a need for early immune-modulators for severe cases. KY Lee, JW Rhim, JH Kang, Med Hypotheses 2011 76 64 69 10.1016/j.mehy.2010.08.032 20822853
50. Critical role of natural killer cells in lung immunopathology during influenza infection in mice. MF Abdul-Careem, MF Mian, G Yue, A Gillgrass, MJ Chenoweth, NG Barra, MV Chew, T Chan, AA Al-Garawi, M Jordana, AA Ashkar, J Infect Dis 2012 206 167 177 10.1093/infdis/jis340 22561366
51. Interleukin-15 is critical in the pathogenesis of influenza a virus-induced acute lung injury. R Nakamura, N Maeda, K Shibata, H Yamada, T Kase, Y Yoshikai, J Virol 2010 84 5574 5582 10.1128/JVI.02030-09 20335267
52. Changes in cytokine levels and NK cell activation associated with influenza. S Jost, H Quillay, J Reardon, E Peterson, RP Simmons, BA Parry, NN Bryant, WD Binder, M Altfeld, PLoS One 2011 6 25060 10.1371/journal.pone.0025060 21966414
53. The pathogenesis of influenza virus infections: the contributions of virus and host factors. S Fukuyama, Y Kawaoka, Curr Opin Immunol 2011 23 481 486 10.1016/j.coi.2011.07.016 21840185
54. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. JF Bermejo-Martin, R Ortiz de Lejarazu, T Pumarola, J Rello, R Almansa, P Ramirez, I Martin-Loeches, D Varillas, MC Gallegos, C Seron, D Micheloud, JM Gomez, A Tenorio-Abreu, MJ Ramos, ML Molina, S Huidobro, E Sanchez, M Gordón, V Fernández, A Del Castillo, MA Marcos, B Villanueva, CJ López, M Rodríguez-Domínguez, JC Galan, R Cantón, A Lietor, S Rojo, JM Eiros, C Hinojosa, et al. Crit Care 2009 13 201 10.1186/cc8208 20003352
55. Modeling host responses in ferrets during A/California/07/2009 influenza infection. T Rowe, AJ Leon, CJ Crevar, DM Carter, L Xu, L Ran, Y Fang, CM Cameron, MJ Cameron, D Banner, DC Ng, R Ran, HK Weirback, CA Wiley, DJ Kelvin, TM Ross, Virology 2010 401 257 265 10.1016/j.virol.2010.02.020 20334888
56. Severe seasonal influenza in ferrets correlates with reduced interferon and increased IL-6 induction. N Svitek, PA Rudd, K Obojes, S Pillet, V von Messling, Virology 2008 376 53 59 10.1016/j.virol.2008.02.035 18420248
57. Protection from lethal influenza virus challenge by oral type 1 interferon. MW Beilharz, JM Cummins, AL Bennett, Biochem Biophys Res Commun 2007 355 740 744 10.1016/j.bbrc.2007.02.019 17316562
58. Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. BL Haagmans, T Kuiken, BE Martina, RA Fouchier, GF Rimmelzwaan, G van Amerongen, D van Riel, T de Jong, S Itamura, KH Chan, M Tashiro, AD Osterhaus, Nat Med 2004 10 290 293 10.1038/nm1001 14981511
59. Sensing of viral infection and activation of innate immunity by toll-like receptor 3. E Vercammen, J Staal, R Beyaert, Clin Microbiol Rev 2008 21 13 25 10.1128/CMR.00022-07 18202435
60. Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. R Le Goffic, V Balloy, M Lagranderie, L Alexopoulou, N Escriou, R Flavell, M Chignard, M Si-Tahar, PLoS Pathog 2006 2 53 10.1371/journal.ppat.0020053 16789835
61. Role of human Toll-like receptors in naturally occurring influenza A infections. N Lee, CK Wong, DS Hui, SK Lee, RY Wong, KL Ngai, MC Chan, YJ Chu, AW Ho, GC Lui, BC Wong, SH Wong, SP Yip, PK Chan, Influenza Other Respir Viruses 2013 7 666 675 10.1111/irv.12109 23552014
62. Attenuation of the influenza virus sickness behavior in mice deficient in Toll-like receptor 3. JA Majde, L Kapas, SG Bohnet, A De, JM Krueger, Brain Behav Immun 2010 24 306 315 10.1016/j.bbi.2009.10.011 19861156
63. Characterization of the 2009 pandemic A/Beijing/501/2009 H1N1 influenza strain in human airway epithelial cells and ferrets. P Yang, J Deng, C Li, P Zhang, L Xing, Z Li, W Wang, Y Zhao, Y Yan, H Gu, X Liu, Z Zhao, S Zhang, X Wang, C Jiang, PLoS One 2012 7 46184 10.1371/journal.pone.0046184 23049974
64. Increased lung neutrophil apoptosis and inflammation resolution in nonresponding pneumonia. I Moret, MJ Lorenzo, B Sarria, E Cases, E Morcillo, M Perpina, JM Molina, R Menendez, Eur Respir J 2011 38 1158 1164 10.1183/09031936.00190410 21436352
65. Cytokines and neutrophils responses in influenza pneumonia. JM Bordon, S Uriarte, FW Arnold, R Fernandez-Botran, M Rane, P Peyrani, R Cavallazzi, M Saad, J Ramirez, Infection 2013 41 1021 1024 10.1007/s15010-013-0461-8 23589279